Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

ORTHOTOPIC LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS

ORTHOTOPIC LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS ANNALS OF SURGERY Marsh, J. W., Iwatsuki, S., Makowka, L., Esquivel, C. O., Gordon, R. D., Todo, S., Tzakis, A., Miller, C., Vanthiel, D., Starzl, T. E. 1988; 207 (1): 21-25

Abstract

The incidence or diagnostic rate of sclerosing cholangitis is increasing. Because of the lack of effective medical or surgical therapy for patients with end-stage liver disease and sclerosing cholangitis, results with orthotopic liver transplantation were examined. The results of 55 consecutive liver replacements for this disease were reviewed. The 1- and 2-year actuarial survival rates are 71% and 57%, respectively. Orthotopic liver transplantation for end-stage liver disease from sclerosing cholangitis has emerged as the most effective therapy.

View details for Web of Science ID A1988L633700005

View details for PubMedID 2827593

View details for PubMedCentralID PMC1493239